USPTO serial 79281114
BIOTTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 2, 2021
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BIOTTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kiranjit K Dharsan
Kiranjit K Dharsan Seiter IP1110 N Virgil Ave, Suite #98436Los Angeles, CA 90029United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for use as semi-finished products in the manufacture of medicines and pharmaceuticals; chemical substances for use as semi-finished products in the manufacture of cosmetics; substances of natural origin in the nature of plant extracts, plant and animal fats, as well as organic and inorganic compounds, namely, oxides, dioxides, acids, bases and salts of minerals, non-carbon containing and carbon dioxide, carbonic acid and its salts, mineral substances being macro elements, namely, calcium, phosphorus, magnesium, potassium, sodium, chlorine, sulfur, nitrogen, oxygen, hydrogen, carbon, mineral substances being microelements, namely, iron, zinc, copper, manganese, iodine, fluorine, selenium and chromium, and mineral substances being ultra-trace elements, namely, nickel, cobalt and vanadium; mineral salts, chemical elements and their salts and trace elements obtained from bacteria or phages or from plant or animal cells and tissues, for use as semi-finished products in the manufacture of medicines and pharmaceuticals; substances of natural origin in the nature of plant extracts, plant and animal fats, as well as organic and inorganic compounds, namely, oxides, dioxides, acids, bases and salts of minerals, non-carbon containing and carbon dioxide, carbonic acid and its salts, mineral substances being macro elements, namely, calcium, phosphorus, magnesium, potassium, sodium, chlorine, sulfur, nitrogen, oxygen, hydrogen, carbon, mineral substances being microelements, namely, iron, zinc, copper, manganese, iodine, fluorine, selenium and chromium, and mineral substances being ultra-trace elements, namely, nickel, cobalt and vanadium; mineral salts, chemical elements and their salts and trace elements obtained from bacteria or phages or from plant or animal cells and tissues, for use as semi-finished products in the manufacture of cosmetics; compositions of chemical substances and/or substances of natural origin in the nature of plant extracts, plant and animal fats, as well as organic and inorganic compounds, namely, oxides, dioxides, acids, bases and salts of minerals, non-carbon containing and carbon dioxide, carbonic acid and its salts, mineral substances being macro elements, namely, calcium, phosphorus, magnesium, potassium, sodium, chlorine, sulfur, nitrogen, oxygen, hydrogen, carbon, mineral substances being microelements, namely, iron, zinc, copper, manganese, iodine, fluorine, selenium and chromium, and mineral substances being ultra-trace elements, namely, nickel, cobalt and vanadium; mineral salts, chemical elements and their salts and trace elements obtained from bacteria or phages or from plant or animal cells and tissues, for use as semi-finished products in the manufacture of medicines and pharmaceuticals; compositions of chemical substances and/or substances of natural origin in the nature of plant extracts, plant and animal fats, as well as organic and inorganic compounds, namely, oxides, dioxides, acids, bases and salts of minerals, non-carbon containing and carbon dioxide, carbonic acid and its salts, mineral substances being macro elements, namely, calcium, phosphorus, magnesium, potassium, sodium, chlorine, sulfur, nitrogen, oxygen, hydrogen, carbon, mineral substances being microelements, namely, iron, zinc, copper, manganese, iodine, fluorine, selenium and chromium, and mineral substances being ultra-trace elements, namely, nickel, cobalt and vanadium; mineral salts, chemical elements and their salts and trace elements obtained from bacteria or phages or from plant or animal cells and tissues, for use as semi-finished products in the manufacture of cosmetics | ACTIVE | — |
| 003 | Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; perfumery; essential oils; bleaching preparations for laundry use; cleaning, polishing, scouring and abrasive preparations | ACTIVE | — |
| 005 | Medications for prevention and treatment of civilization diseases, namely, obesity, hypertension, cancer, diabetes, skin and food allergies, autoimmune diseases and neurological diseases, Alzheimer's disease, atherosclerosis, asthma, chronic liver disease, Type 2 diabetes, heart disease, hypertension, osteoporosis, stroke, depression, diverticulitis, gallstones, and for the use in the field of dermatology, infectiology, parasitology, cardiology, otorhinolaryngology, pulmonology, oncology, neurology, haematology, gastroenterology, gynaecology, diabetology, tissue regeneration and plastic surgery; pharmaceutical products, namely semi-solid forms of drugs to be applied on the surface of the skin, namely creams, gels and ointments, drugs applied through/from plasters, dressings, poultices, cataplasms and transdermal therapeutic systems, fluid drug forms, namely solutions, suspensions and emulsions, solid drug forms, namely tablets and capsules, all of them to be used for purposes of prevention and treatment of civilization diseases, namely, obesity, hypertension, cancer, diabetes, skin and food allergies, autoimmune diseases and neurological diseases, Alzheimer's disease, atherosclerosis, asthma, chronic liver disease, Type 2 diabetes, heart disease, hypertension, osteoporosis, stroke, depression, diverticulitis, gallstones, hypertension, cancer, diabetes, skin and food allergies, autoimmune diseases}, as well as neurological, dermatological, infectiological, cardiological, otorhinolaryngological, pulmonological, oncological, haematological, gastroenterological, gynaecological and diabetological diseases, in tissue regeneration, plastic surgery and in parasitology; medical and veterinary preparations in semi-solid forms to be applied on the surface of the skin, namely creams, gels and ointments, in forms applied through/from plasters, dressings, poultices, cataplasms and transdermal therapeutic systems, in fluid forms, namely solutions, suspensions and emulsions, in solid forms, namely in tablets and capsules, all of them to be used for purposes of prevention and treatment of human civilization diseases, namely, obesity, hypertension, cancer, diabetes, skin and food allergies, autoimmune diseases and neurological diseases, Alzheimer's disease, atherosclerosis, asthma, chronic liver disease, Type 2 diabetes, heart disease, hypertension, osteoporosis, stroke, depression, diverticulitis, gallstones, hypertension, cancer, diabetes, skin and food allergies, autoimmune diseases}, as well as neurological, dermatological, infectiological, cardiological, otorhinolaryngological, pulmonological, oncological, haematological, gastroenterological, gynaecological and/or diabetological diseases, in tissue regeneration, plastic surgery and in parasitology, sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical or veterinary use, including dietetic foods and beverages containing plant extracts, plant and animal fats, organic and inorganic compounds, mineral substances, mineral salts, chemical elements and their salts and/or trace elements; infant formula; dietary supplements for animals; dietary supplements for humans; plasters for medical purposes, namely plasters for dressing and protecting wounds, cuts and abrasions and/or for preventing infections and plasters used for the treatment of dermatological diseases, plasters used in transdermal therapeutic systems for systemically dosing active therapeutic substances; materials for dressings; teeth filling material; dental impression materials; disinfectants; preparations for destroying vermin; fungicides; herbicides | ACTIVE | — |
| 042 | Scientific and technological services in the field of chemistry, biology, biotechnology, cosmetology, stomatology, medicine, pharmacy, veterinary, hygiene, dietary supplements production, food and beverages production, plant protection, agriculture, horticulture and forestry and phage therapy, namely, conducting scientific or technological research, tests, trials and analyses; research and design services, namely, services rendered for producers of chemical substances or compositions of chemical substances and substances of natural origin, cosmetics and toiletry preparations, dentifrices, perfumery products and essential oils, bleaching, cleaning, polishing, scouring or abrasive preparations, medications, pharmaceutical products, medical or veterinary preparations, medical or veterinary devices, sanitary products and preparations, foods, beverages, dietetic foods and beverages, infant formula, dietary supplements for humans or animals; plasters and materials for dressings; teeth filling materials and dental impression materials, disinfectants, preparations for destroying vermin, fungicides, herbicides, preparations for weed and pest control, manures and fertilizers, plant protection products, vaccines, plant vaccines and products obtained from phages, consisting in design, preceded by scientific or technological research, of new products, new product forms, new recipes, formulas, compositions and/or mixtures for production, new technological processes and/or new production lines, in improvement, correction, modification or modernization, preceded by scientific or technological research, of existing products, product forms, recipes, formulas, compositions and/or mixtures for production, technological processes and/or production lines, in design of new ecological production solutions to replace non-ecological ones, in design of natural substitutes for synthetic ones, in design of solutions aiming at increasing the bioavailability of the existing preparations, at ensuring the maintenance and stabilization of products using natural resources, at increasing penetration of active substances, at modification of product taste and smell basing on natural ingredients, at stabilization of omega acids in oils; industrial research and analysis services, namely services rendered for producers of chemical substances or compositions of chemical substances and substances of natural origin, cosmetics and toiletry preparations, dentifrices, perfumery products and essential oils, bleaching, cleaning, polishing, scouring or abrasive preparations, medications, pharmaceutical products, medical or veterinary preparations, medical or veterinary devices, sanitary products and preparations, foods, beverages, dietetic foods and beverages, infant formula, dietary supplements for humans or animals; plasters and materials for dressings; teeth filling materials and dental impression materials, disinfectants; preparations for destroying vermin, fungicides, herbicides, preparations for weed and pest control, manures and fertilizers, plant protection products, vaccines, plant vaccines and products obtained from phages and consisting in research and analyses as to product composition and formulation, in laboratory tests and analyses of their results, in chemical, physiochemical, microbiological, toxicological, allergological and dermatological tests and analyses, in product activity, quality, safety, maintenance and stability tests and analyses, in product technological trials and in preparing and providing the documentation containing the description and results of the carried out tests and analyses; design and development of computer hardware and software | ACTIVE | — |
| 044 | Medical services; veterinary services; human hygienic and beauty care; hygienic and beauty care for animals; beauty salons; agriculture, horticulture and forestry services, namely, information, advisory and consultancy services relating to weed, pest and vermin control in agriculture, horticulture and forestry, to the use of chemicals, manures and fertilizers in agriculture, horticulture and forestry, to the use of plant protection products, plant vaccines and phages in agriculture, horticulture and forestry, to the farming and cultivation in agriculture, horticulture and forestry with use of innovative chemical, biological and biotechnological processes and their products and to the recultivation of industrial wastelands for agriculture, horticulture and forestry purposes with use of innovative chemical, biological and biotechnological processes and their products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOTTS S.A.
- Other trademarks owned by BIOTTS S.A.
- Other trademarks owned by BIOTTS S.A.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIOTTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 25, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 25, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 25, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 15, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 23, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 23, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 8, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 8, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 8, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 25, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 26, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 5, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 15, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 15, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 15, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 14, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 21, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |